Efficacy, Tolerability and Safety of Intramuscular Injections of PLX PAD for the Treatment of Subjects With Critical Limb Ischemia (CLI) With Minor Tissue Loss Who Are Unsuitable for Revascularization

Investigator(s):
Isabella Jade Kuo, M.D.;
Organization: 
UCI
NCT Number: 
NCT03006770
Disease Name: 
Critical Limb Ischemia
Disease Category: 
Blood
Trial Phases: 
Phase 3
Trial Status: 
Active, Not Recruiting
Trial Contact: 

Active trials at UCI: http://clinic.stemcell.uci.edu/search-clinical-trials.asp

Contact for all open studies at UCI:
(949) 824-3990
stemcell@uci.edu